Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital — Dallas, Texas

Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital?

Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital conducted?

Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital has 2 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.

Is Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital accredited by Crixeo Health?

Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.